A detailed history of Dimensional Fund Advisors LP transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 33,152 shares of SCPH stock, worth $111,390. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,152
Previous 135,080 75.46%
Holding current value
$111,390
Previous $587,000 74.28%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$4.12 - $5.51 $419,943 - $561,623
-101,928 Reduced 75.46%
33,152 $151,000
Q2 2024

Aug 09, 2024

SELL
$3.51 - $5.21 $109,287 - $162,218
-31,136 Reduced 18.73%
135,080 $587,000
Q1 2024

May 10, 2024

SELL
$4.86 - $6.39 $35,755 - $47,011
-7,357 Reduced 4.24%
166,216 $834,000
Q4 2023

Feb 07, 2024

SELL
$4.7 - $6.63 $127,981 - $180,534
-27,230 Reduced 13.56%
173,573 $1.09 Million
Q3 2023

Nov 09, 2023

SELL
$7.0 - $9.82 $45,290 - $63,535
-6,470 Reduced 3.12%
200,803 $1.43 Million
Q1 2023

May 12, 2023

SELL
$5.59 - $9.47 $44,524 - $75,428
-7,965 Reduced 3.7%
207,273 $1.88 Million
Q4 2022

Feb 09, 2023

BUY
$4.02 - $7.53 $305,998 - $573,176
76,119 Added 54.72%
215,238 $1.54 Million
Q3 2022

Nov 10, 2022

BUY
$4.48 - $6.52 $101,592 - $147,854
22,677 Added 19.47%
139,119 $906,000
Q2 2022

Aug 12, 2022

BUY
$4.3 - $6.48 $55,504 - $83,643
12,908 Added 12.47%
116,442 $561,000
Q1 2022

May 13, 2022

BUY
$3.9 - $6.11 $26,469 - $41,468
6,787 Added 7.02%
103,534 $588,000
Q4 2021

Feb 09, 2022

BUY
$3.88 - $6.9 $67,830 - $120,625
17,482 Added 22.06%
96,747 $485,000
Q3 2021

Nov 12, 2021

BUY
$4.93 - $7.15 $169,779 - $246,231
34,438 Added 76.82%
79,265 $527,000
Q2 2021

Aug 12, 2021

SELL
$5.19 - $7.38 $10,644 - $15,136
-2,051 Reduced 4.38%
44,827 $273,000
Q4 2020

Feb 25, 2021

BUY
$5.17 - $9.41 $242,359 - $441,121
46,878 New
46,878 $248,000

Others Institutions Holding SCPH

About scPharmaceuticals Inc.


  • Ticker SCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,402,100
  • Market Cap $92.1M
  • Description
  • scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...
More about SCPH
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.